Clinical Trial: A Phase II Study to Evaluate the Efficacy and Safety of D-2570 in Participants With Moderate to Severe Plaque Psoriasis

U.S., March 25 -- ClinicalTrials.gov registry received information related to the study (NCT07489885) titled 'A Phase II Study to Evaluate the Efficacy and Safety of D-2570 in Participants With Moderate to Severe Plaque Psoriasis' on March 18.

Brief Summary: A Study looking at the safety and efficacy of D-2570 in Participants with Plaque Psoriasis

Study Start Date: May, 2026

Study Type: INTERVENTIONAL

Condition: Psoriasis

Intervention: DRUG: D-2570 Tablet

Active Treatment

DRUG: Placebo Tablets

Identical Tablet

Recruitment Status: NOT_YET_RECRUITING

Sponsor: InventisBio Co., Ltd

Disclaimer: Curated by HT Syndication....